March 25, 2025 06:30 PM EDT
People
FDA+

Covid con­trar­i­an Bhat­tacharya is con­firmed as NIH chief, tak­ing over at a fraught mo­ment for fed­er­al re­search

Max Bayer

Pharma Reporter

Stan­ford re­searcher Jay Bhat­tacharya has been con­firmed as the new head of the NIH, tak­ing over the once-sta­ble sci­ence agency that’s at the cen­ter of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sen­ate con­firms Makary as FDA chief with agency cuts, re­turn-to-of­fice in force

Lyn­dra Ther­a­peu­tics to wind down amid fund­ing hur­dles for long-act­ing drug tech­nol­o­gy

WuXi Bi­o­log­ics’ li­cens­ing deals help off­set Biose­cure threat in the US

Ei­sai cuts Leqem­bi 2027 sales fore­cast by half but ex­pects 'con­tin­ued growth'

GSK scores FDA ap­proval for an­tibi­ot­ic to treat un­com­pli­cat­ed UTIs

Mer­ck strikes deal for heart drug, worth up to $2B, with Chi­na’s Hen­grui

A service from the Financial Times